Walloon radioisotope in the fight against cancer
October 23, 2017 - Comments Off on Walloon radioisotope in the fight against cancerWallonia can pride itself on harbouring some of the key players in the radiopharmaceutical sector. IRE/IRE-Elit, Trasis and ANMI – to name but three of those in the field – are innovative companies that are applying their know-how and experience […]
Personalised arthritis medicine saves lots of money
April 06, 2017 - Comments Off on Personalised arthritis medicine saves lots of moneyDetecting arthritis early on is one of the key challenges facing rheumatology. However, some patients present with undifferentiated arthritis, meaning that it is not possible to establish a diagnosis from the initial assessment. By analyzing our genes and other factors […]
Adrenaline junkie? Raising capital could be for you!
January 19, 2017 - Comments Off on Adrenaline junkie? Raising capital could be for you!Raising capital is no easy task and demands a great deal of time and energy. We interviewed Kitozyme CEO François Blondel, who agreed to share his experience of running several campaigns to raise capital. We also talked to KiOmed Pharma, […]
BioWin supports the ‘SMART’ project
December 22, 2016 - Comments Off on BioWin supports the ‘SMART’ projectProviding software that is able to analyse, compare and measure huge amounts of data clinical trials, with the aim of detecting anomalies: this is what the company CluePoints accomplished. CluePoints is the outcome of the BioWin ‘SMART’ (Statistical Monitoring Applied […]
Latest Articles
One in eleven adults around the world has diabetes, according to figures published by the International Diabetes Federation (IDF) in 2017. A research team, [...]
Wallonia can pride itself on harbouring some of the key players in the radiopharmaceutical sector. IRE/IRE-Elit, Trasis and ANMI – to name but three [...]
Detecting arthritis early on is one of the key challenges facing rheumatology. However, some patients present with undifferentiated arthritis, meaning that it is not [...]
Raising capital is no easy task and demands a great deal of time and energy. We interviewed Kitozyme CEO François Blondel, who agreed to [...]
Providing software that is able to analyse, compare and measure huge amounts of data clinical trials, with the aim of detecting anomalies: this is [...]
In 2013, a new BioWin project, NeuroAtt, was launched to enable making a reliable diagnosis for ADHD (Attention Deficit Hyperactivity Disorder) and to find [...]
Quality Assistance is ready for the onslaught of requests for the assessment of elemental impurities in substances used in the development and manufacture of [...]
The continuous flow in jet-induced fountains inspired Nourredine Frid, CEO at Cardiatis (Isnes), to apply the theory of fluid mechanics to blood vessels. By [...]
Founded in 2011, iTeos began its activities at the end of 2012. The company is active in the field of cancer immunotherapy and focuses [...]
In 2016 and beyond, biomanufacturing will be high among the BioWin pole priorities. A sector in which Wallonia has no shortage of qualified players [...]
